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Abstract: Background Takotsubo syndrome (TTS) is characterized by often reversible but acute heart
failure occurring after an emotional or physical trigger event. The ’brain failure’ counterpart is posterior
reversible encephalopathy syndrome (PRES) characterized by often reversible but acute neurological
symptoms. This case report elaborates on a complex clinical scenario with co-existence of coronary artery
disease, TTS and PRES and discusses the pathophysiology, differential diagnosis, and management.
Case summary An 82-year-old woman presented with acute heart failure and generalized tonic-clonic
seizures following an acute exacerbation of her chronic back pain. Brain magnetic resonance imaging
demonstrated vasogenic oedema consistent with the diagnosis of PRES. Focal wall motion abnormalities
on echocardiography without causal coronary stenoses on angiography were consistent with the diagnosis
of TTS. After an interdisciplinary approach to differential diagnosis and treatment, the patient was
discharged to geriatric rehabilitation without heart failure or neurological defects 4 weeks later. Discussion
TTS and PRES share significant similarities in proposed pathogenesis, epidemiology, management, and
clinical outcome. This case report highlights the need for early recognition of this rare association and
multidisciplinary approach to diagnosis and treatment as both heart and brain disease may require early
intervention up to rapid intensive care support.
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Background Takotsubo syndrome (TTS) is characterized by often reversible but acute heart failure occurring after an emotional
or physical trigger event. The ‘brain failure’ counterpart is posterior reversible encephalopathy syndrome (PRES)
characterized by often reversible but acute neurological symptoms. This case report elaborates on a complex clin-
ical scenario with co-existence of coronary artery disease, TTS and PRES and discusses the pathophysiology, differ-
ential diagnosis, and management.
...................................................................................................................................................................................................
Case summary An 82-year-old woman presented with acute heart failure and generalized tonic-clonic seizures following an acute ex-
acerbation of her chronic back pain. Brain magnetic resonance imaging demonstrated vasogenic oedema consistent with
the diagnosis of PRES. Focal wall motion abnormalities on echocardiography without causal coronary stenoses on angiog-
raphy were consistent with the diagnosis of TTS. After an interdisciplinary approach to differential diagnosis and treat-
ment, the patient was discharged to geriatric rehabilitation without heart failure or neurological defects 4 weeks later.
...................................................................................................................................................................................................
Discussion TTS and PRES share significant similarities in proposed pathogenesis, epidemiology, management, and clinical out-
come. This case report highlights the need for early recognition of this rare association and multidisciplinary ap-
proach to diagnosis and treatment as both heart and brain disease may require early intervention up to rapid inten-
sive care support.
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Introduction
Takotsubo syndrome (TTS) is an acute heart failure syndrome
clinically mimicking acute coronary syndrome (ACS).1,2 TTS
Learning points
• In postmenopausal women with symptoms of acute coronary syndrome or acute heart failure, takotsubo syndrome should always be a dif-
ferential diagnosis, particularly in cases with concomitant neurologic events or physical/emotional triggers and unexplained clinical findings.
• Takotsubo syndrome and posterior reversible encephalopathy syndrome are associated diseases, which share significant similarities in pro-
posed pathogenesis, epidemiology, and clinical outcome.
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predominantly affects postmenopausal women,1–3% of all and 5–6%
of female patients presenting with suspected ACS suffer from TTS.1
Physical or emotional triggers are present in more than 70% of cases
and rates of concomitant psychiatric or neurologic disorders are con-
siderably higher in patients with TTS compared to age- and gender-
matched patients with ACS.3 TTS had initially been considered a benign
disease, however, different studies have since demonstrated similar
rates of severe in-hospital complications to ACS patients, even if
treated according to current guidelines.3,4 The exact pathophysiology
of TTS is unknown, but sympathetic stimulation with catecholamine ex-
cess seems to have a central role, consecutive impaired microvascular
endothelial function is a typical finding in patients with TTS.1,5,6
Posterior reversible encephalopathy syndrome (PRES) is charac-
terized by an acute onset of neurological symptoms and vasogenic
oedema on brain magnetic resonance imaging (MRI).7 PRES may af-
fect all age groups but shows a female preponderance.8 In most cases
symptoms and radiologic abnormalities resolve within days to weeks.9
Pathophysiologically, cerebral hyperperfusion caused by increasing
blood pressure is thought to allow for plasma extravasation leading to
cerebral oedema, while alternative theories favour endothelial dys-
function with increased vascular permeability caused by endogenous
or exogenous toxins.7–9
In summary, both TTS and PRES present with acute cardiac or
neurological symptoms, share a female preponderance and vascular
oedema on imaging, and may resolve spontaneously within days. In
this case report, we present a patient suffering from concomitant
acute heart failure and neurological symptoms, and discuss differen-
tial diagnosis, management, and similarities of TTS and PRES.
Timeline
Case presentation
An 82-year-old woman with a past medical history of valvular heart
and coronary artery disease (CAD), stroke, diabetes, atrial fibrillation,
.................................................................................................
Time Progress




normal left ventricular ejection
fraction (LVEF) (83%)
Day 1
Early in the morning Heavy back pain
11:00 Generalized tonic-clonic seizure of
several minutes
12:00 Admission to the emergency depart-
ment of a secondary-care
hospital:
Beside back pain, no discomfort, no
pectanginous symptoms
Glasgow Coma Scale (GCS) 15,
blood pressure 171/91mmHg,
oxygen saturation of 93% on 4 L/
min of oxygen, pulmonary oe-






12:15 ST-segment elevation in V2–V3 in
electrocardiography
13:26 CT showed unspecific cerebellar
hypodensity
13:58 Troponin 76 ng/L (normal < 14 ng/
L), creatine kinase within normal
limits, N-terminal prohormone of
brain natriuretic peptide
21 219 ng/L (normal < 738 ng/L)
18:31 Magnetic resonance imaging (MRI)
demonstrated vasogenic oedema
in the cerebellum, pons, and pos-
terior lobe
Day 4 Transthoracic echocardiography
showed an LVEF of 45% with akin-
esia of the entire apex extending
to the midventricular segments
Day 6
19:38 Transfer to our cardiology ward for
left heart catheterization, which
was not feasible due to agitation
and disorientation of the patient
20:47 Transthoracic echocardiography
demonstrated LVEF of 32% with
akinesia of the entire apex
extending to the midventricular
segments of the left and right ven-
tricle (including akinesia of the
right free wall) and a moderate to
severe low-flow–low-gradient
aortic stenosis
Day 13 CT ruled out aortic dissection and
pulmonary embolism, but demon-
strated new osteoporotic frac-
tures of the thoracic spine
Days 7–18 Intermittent episodes of decreased
consciousness, agitation and dis-
orientation, acute renal failure,
and electrolyte disturbances
Day 19 Coronary angiography and right cor-
onary artery percutaneous
intervention
Day 28 Follow-up echocardiography dem-
onstrated normalized LVEF






















































































































































































































































chronic kidney disease, and osteoporosis presented in a secondary-
care hospital after a generalized tonic-clonic seizure following an
acute exacerbation of her chronic back pain. The patient complained
of back pain, but denied chest pain or dyspnoea. On admission ele-
vated blood pressure (171/91mmHg) was noted, oxygen saturation
was 93% on 4 L/min of oxygen and there were signs of biventricular
acute heart failure with fine bibasilar crackles indicating pulmonary
oedema, elevated jugular venous pressure, and swelling of the lower
extremities. A delayed left-sided pupillary response was noted while
the neurological status was otherwise unremarkable. The patients
long-term medication consisted of apixaban 5mg b.i.d., lisinopril
20mg/day, torasemide 30mg/day, levothyroxine 100mg/day, acet-
aminophen 4 g/day, metamizole 3 g/day, fentanyl patch 50mg/24h,
and amitriptyline 25mg/day. Electrocardiography (ECG) docu-
mented sinus rhythm with intermittent ST-segment elevation in the
precordial leads (Figure 1). Laboratory tests revealed a markedly
increased N-terminal prohormone of brain natriuretic peptide (at ad-
mission: 21 219 ng/L, max. 59 475 ng/L, normal <738 ng/L) and only
modestly elevated troponin values (at admission 76ng/L, max.
204ng/L, normal <14ng/L), while creatine kinase repetitively
remained normal. Brain MRI demonstrated bilateral cerebellar and
occipital vasogenic oedema (Figure 2) consistent with PRES.
Echocardiography demonstrated a newly reduced left ventricular
ejection fraction (LVEF) with apical akinesia and the patient was trans-
ferred to our hospital for left heart catheterization.
Immediate left heart catheterization was planned but initially not
feasible due to agitation and disorientation of the patient.
Transthoracic echocardiography in our hospital showed a normally
configurated left ventricle with a severely reduced biventricular
ejection fraction with akinesia of the entire apex extending to the
midventricular segments as well as akinesia of the right free wall
and a moderate to severe low-flow–low-gradient aortic stenosis
(Supplementary material online, Videos S1–S3). Computed tomog-
raphy (CT) ruled out aortic dissection and pulmonary embolism
but demonstrated new osteoporotic fractures of the thoracic
spine. Concomitant CT angiography demonstrated high-grade dif-
fuse arteriosclerosis and a stented right coronary artery (RCA)
with preserved flow in all distal coronary arteries, rendering reli-
able quantification of coronary stenosis inconclusive. Invasive cor-
onary angiography revealed serial 90% stenoses in the mid-
segment of the left circumflex artery (LCX) and a proximal 80%
in-stent restenosis in the previously stented RCA (Figure 3 and
Supplementary material online, Videos S4 and S5). The left anterior
descending artery (LAD) itself demonstrated no significant
lesions. Left ventriculography was not conducted due to previous-
ly performed echocardiography and acute on chronic renal failure.
The RCA was treated with a drug-eluting stent (Supplementary
material online, Video S6), the stenoses in the LCX were not
treated simultaneously because of increased agitation of the pa-
tient, which was considered acceptable due to small vessel size,
sufficient collateral flow, and lack of angina. Follow-up ECG
showed new biphasic T-wave inversions in the precordial leads
and QTc prolongation (Figure 4), while laboratory tests demon-
strated no signs of increasing troponin leakage. Given the
Figure 1 Initial electrocardiography showing sinus rhythm and ST-segment elevation in V2–V3.
Acute heart and brain failure 3
Figure 3 Coronary angiography. (A) The arrows indicate a serial 90% stenosis in the left circumflex artery. (B) The arrow indicates an 80% proximal
in-stent stenosis in the right coronary artery.
Figure 2 Brain magnetic resonance imaging (T2 weighted). (A) The arrow indicates vasogenic oedema in the posterior cerebral lobe. (B) The arrow
indicates vasogenic oedema in the cerebellum.












characteristic wall motion pattern with apical ballooning with
reduced LVEF and a coronary pathology not explaining the wall mo-
tion abnormality in context with ST-segment elevation and pro-
longed QTc with subsequent T-wave inversion, TTS with
concomitant obstructive CAD and PRES was considered as the most
appropriate diagnosis and the initial back pain exacerbation due to
fractures in the thoracic spine appeared a likely trigger for the TTS
event (Table 1).
Figure 4 Electrocardiography showing T-wave inversions in I and aVL, biphasic T-wave inversions in V2–V6, and QTc prolongation onDay 13.
Table 1 International Takotsubo Diagnostic Criteria have been developed and published in 2018 by Ghadri et al1.
Compared to previous criteria they take into account that coronary artery disease is not a contradiction in TTS. In our
case all diagnostic criteria for TTS were met
1. Patients show transienta left ventricular dysfunction (hypokinesia, akinesia, or dyskinesia) presenting as apical ballooning or midventricular, basal, or
focal wall motion abnormalities. Right ventricular involvement can be present. Besides these regional wall motion patterns, transitions between all
types can exist. The regional wall motion abnormality usually extends beyond a single epicardial vascular distribution; however, rare cases can exist
where the regional wall motion abnormality is present in the subtended myocardial territory of a single coronary artery (focal TTS)b
2. An emotional, physical, or combined trigger can precede the TTS event, but this is not obligatory
3. Neurologic disorders (e.g. subarachnoid haemorrhage, stroke/transient ischaemic attack, or seizures) as well as pheochromocytoma may serve as trig-
gers for TTS
4. New ECG abnormalities are ent (ST-segment elevation, ST-segment depression, T-wave inversion, and QTc prolongation); however, rare cases exist
without any ECG changes
5. Levels of cardiac biomarkers (troponin and creatine kinase) are moderately elevated in most cases; significant elevation of brain natriuretic peptide is
common
6. Significant coronary artery disease is not a contradiction in TTS
7. Patients have no evidence of infectious myocarditisb
8. Postmenopausal women are predominantly affected
aWall motion abnormalities may remain for a prolonged period of time or documentation of recovery may not be possible. For example, death before evidence of recovery is
captured.
bCardiac magnetic resonance imaging is recommended to exclude infectious myocarditis and diagnosis confirmation of TTS.
Reprinted with permission of Ghadri et al1.














































































































































































The patient was treated with analgesia to minimize recurrent trig-
gers (acetaminophen 4 g/day, metamizole 3 g/day, hydromorphone
max. 32mg/day), levetiracetam 1000mg/day to prevent recurrent
seizures, dual antiplatelet medication (aspirin 100mg/day, clopidogrel
75mg/day) after coronary artery stenting and intensive heart failure
therapy including angiotensin-converting enzyme inhibitors (lisinopril
2.5–10mg/day, dose was limited by symptomatic hypotension and
acute on chronic renal failure) and loop diuretics (varying doses of
furosemide IV, max. 70mg/days or torasemide oral, max. 50mg/
days). Because of bradycardia and hypotension, beta-blockers were
postponed. Since the patient refused cardiopulmonary resuscitation,
heart rhythm monitoring was not performed despite QTc
prolongation.
While heart failure symptoms improved, the clinical course was
complicated by intermittent episodes of decreased consciousness,
acute renal failure, and electrolyte disturbances.
Electroencephalography demonstrated no evidence of epileptic poten-
tials and CT ruled out intracranial haemorrhage, hence we suspected
either prolonged PRES symptoms or hypoactive delirium and installed
continuous observation and conservative anti-delirious measures.
Follow-up cerebral MRI 5 weeks later showed resolution of the vaso-
genic brain oedema. Follow-up echocardiography 4 weeks later dem-
onstrated complete normalization of LVEF without any residual wall
motion abnormalities (Supplementary material online, Videos S7–S9).
The patient was discharged 4 weeks after hospital admission with-
out evidence of heart failure and without clinically apparent neuro-
logical defects to geriatric rehabilitation. The discharge medication
included ramipril 1.25mg/day for TTS, aspirin 100mg/day and clopi-
dogrel 75mg/day after percutaneous coronary intervention on top
of edoxaban 30mg/day for atrial fibrillation, pantoprazole 40mg/day,
torasemide 2.5mg/day, levothyroxine 100mg/day, and acetamino-
phen 4 g/day plus buprenorphine patch 35mg/24 h for chronic back
pain. Levetiracetam was stopped after resolution of vasogenic oe-
dema on cerebral MRI. Regular check-ups for adaption of lisinopril,
torasemide, and edoxaban at the patient’s general practitioner were
planned, as well as cardiologic and neurologic follow-up after
3months at an outpatient clinic.
Discussion
This case report illustrates challenges in diagnostic and management
strategies in patients with TTS and concomitant CAD, as well as a po-
tential association of TTS with patients suffering from PRES.
Acute systolic heart failure with troponin elevation and electrocar-
diographic alterations may be caused by several causal diseases, of
which ACS, TTS, and myocarditis are often primarily considered. If
TTS is suspected, the InterTAK diagnostic score can be used to esti-
mate probability of TTS using clinical criteria,10 which resulted in a
InterTAK score >50 for our patient, making TTS highly likely.
Concerning further diagnostic strategies, coronary angiography and
left ventriculography are considered the gold standard to confirm
TTS and rule out ACS.1 But the diagnosis of CAD by invasive angiog-
raphy is not at all a contradiction to TTS as these diseases often coex-
ist, rendering differential diagnosis and interpretation of stenoses on
invasive angiograms difficult.1 In acute critical conditions, coronary
CT angiography may be considered to rule out progression of CAD,
but it may be of limited value in diffuse arteriosclerosis or previously
stented coronary arteries, similar to our patient.4 Cardiac MRI can
differentiate between TTS, ACS, and myocarditis, but is often not
feasible in patients with concomitant neurological conditions (PRES
in our example) or critical medical state.11Myocarditis was a differen-
tial diagnosis in our patient, but neither a recent infection in the
patient’s history nor a pericardial effusion or laboratory signs of in-
flammation were noted.
Since CT angiography could not exclude progression of CAD and
MRI was not feasible in our patient, we performed invasive angiog-
raphy, where the patient received percutaneous intervention of the
80% in-stent restenosis in the proximal RCA. The latter seems in-
appropriate in retrospect, since biventricular wall motion abnormal-
ities were not consistent with observed coronary lesions and
electrocardiographic changes did not match the invasively docu-
mented stenoses, while the InterTAK score strongly favoured TTS
and dual antiplatelet therapy after coronary intervention is associated
with an excess in bleeding risk. On the other hand, we were faced
with the differential diagnosis of a concomitant ACS, the patient had
known CAD, the RCA was a dominant vessel with a proximal high-
grade stenosis that had previously been stented, there was akinesia of
the right free wall on echocardiography and we could not rule out
overlap of ischaemic and TTS-related wall motion abnormalities. In
this complex situation and even after individual risk stratification, the
benefit of pragmatic revascularization may be equally counterbal-
anced by the associated bleeding risk. After discussing the situation
with the patient, who primarily wanted to avoid a second coronary
angiography in the near future, we decided for revascularization
based on the patient’s preference. Since wall motion abnormalities
with apical ballooning extended above the coronary pathologies, high
InterTAK score was identified and T-wave inversions as well as QTc
prolongation after invasive angiography was noted, we, however,
diagnosed TTS as the most unifying diagnosis, with bystanding CAD.
Even though QTc prolongation is associated with acute neuro-
logical events, to the best of our knowledge no association of QTc
prolongation and PRES has been reported. T-wave inversions after
intermittent ST-elevation can be a sign of reperfusion after throm-
botic or vasospastic ACS, but coronary angiography demonstrated
no lesions in the LAD and we would have expected a spontaneous
reperfusion of a transient thrombotic or vasospastic occlusion to
present more acutely.
This case emphasizes that diagnosis of TTS may be challenging in
the setting of concomitant CAD and that the decision to treat high-
grade stenosis of CAD with concomitant TTS may rely primarily on
individual risk stratification, since both over- and undertreatment of
CAD is possible in this situation.
Concerning the association of TTS and PRES, we presented a pa-
tient with both TTS and concomitant PRES following acute exacerba-
tion of chronic back pain. Both disorders affect predominantly
women and are usually reversible with supportive management, but
can be life-threatening in the acute phase.1,3,4 For TTS, angiotensin-
converting enzyme inhibitors are indicated as conservative heart
failure therapy and have been associated with improved survival and
recovery of left ventricular function.3Beta-blockers also seem to be
reasonable until full recovery of LVEF, although no survival benefit
has been demonstrated.4 QT prolongation is a known substrate for



































ventricular arrhythmia, therefore QT-interval prolonging drugs
should be avoided and rhythm monitoring is warranted.4 For PRES,
the management of the underlying disease, blood pressure control,
and symptomatic control of neurological defects are the mainstay of
current treatment strategies.7,9
Endothelial dysfunction, caused by excessive catecholamine re-
lease and inflammation, has been proposed in both disorders as the
potential underlying mechanism.1,7 In this context, the association of
hypertensive episodes with PRES may merely be a bystander of
catecholamine-induced high blood pressure. Supporting the patho-
physiological relevance of endothelial dysfunction, vasogenic cerebral
oedema on MRI is characteristic of PRES7 while myocardial oedema
is a typical finding on cardiac MRI in TTS.11 A possible association or
link of the two syndromes has previously been reported: in one
study, 6 out of 224 patients (2.7%) with TTS were also diagnosed
with PRES.2 Reviewing data on PubMed, we identified another 8 case
reports of associated PRES and TTS, resulting in a total of 14
patients.2,12–19 Similar to our case, 13 of these 14 patients were fe-
male with an age range of 45–83 years2,12–16,18,19 and 6 patients
developed symptoms of TTS and PRES on the same day,2,15–17,19
while 3 patients suffered from TTS first,2 favouring the theory of a
common pathogenesis over PRES triggering TTS.
Also similar to our case, a physical or emotional trigger was
observed in 12 out of 14 patients.2,12,14–16,18,19 An autoimmune dis-
ease as a potential trigger for endothelial dysfunction was present in
seven patients and three had previously been treated with ste-
roids.2,12 The latter might serve as a trigger for TTS and PRES, since
steroid-induced arterial hypertension is thought to be partially medi-
ated by increased vascular sensitivity to adrenergic agonists.20 One
patient suffered from a drug-induced PRES and TTS due to the
tyrosine-kinase inhibitor lenvatinib. The pathogenesis was suspected
to be mediated by antagonism to vascular endothelial growth factor
reducing nitric oxide through inhibition of nitric oxide synthase,
which may cause an increased response to catecholamines in some
organs.18
In conclusion, while it is reasonable to suggest a common causal
mechanism, the pathophysiological connection of PRES and TTS is
still unclear, but endothelial dysfunction seems to play a major role in
both diseases. Patients with concomitant TTS and PRES seem to ex-
hibit a female preponderance, an advanced age and often identifiable
physical or emotional triggers.
Conclusion
TTS and PRES share significant similarities in proposed pathogenesis,
epidemiology, management, and clinical outcome.
The diagnosis of TTS itself may be challenging, since the clinical
phenotype may closely resemble ACS and both conditions may co-
exist. Therefore, in postmenopausal women with symptoms of ACS
or acute heart failure, TTS should always be a differential diagnosis,
particularly in cases with concomitant neurologic events or physical/
emotional triggers.
In the setting of new heart failure in patients with PRES, TTS should
be suspected—likewise, in the case of new neurological symptoms in
patients with TTS, PRES should be considered as a potential diagno-
sis. However, in cases of co-existence of CAD and TTS there is a
potential risk for both over- and undertreatment of CAD vs. TTS and
management needs to be guided by individual risk stratification and
patient preference.
This case report highlights the need for an early recognition of
these diseases and a multidisciplinary approach to diagnosis and treat-
ment as both heart and brain disease may require early diagnosis, ap-
propriate intervention, and prompt intensive care support.
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